Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional

Journal of Diabetes Investigation ◽

10.1111/jdi.13450 ◽

2020 ◽

Author(s):

Akihisa Imagawa

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Fulminant Type 1 Diabetes ◽

Fulminant Type

Download Full-text

Painless Thyroiditis and Fulminant Type 1 Diabetes Mellitus in a Patient Treated with an Immune Checkpoint Inhibitor, Nivolumab

The Tohoku Journal of Experimental Medicine ◽

10.1620/tjem.244.33 ◽

2018 ◽

Vol 244 (1) ◽

pp. 33-40 ◽

Cited By ~ 22

Author(s):

Kanako Sakurai ◽

Satsuki Niitsuma ◽

Ryota Sato ◽

Kazuhiro Takahashi ◽

Zenei Arihara

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Fulminant Type 1 Diabetes ◽

Painless Thyroiditis ◽

Fulminant Type

Download Full-text

Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus?

Clinical Medicine ◽

10.7861/clinmed.2020-0054 ◽

2020 ◽

Vol 20 (4) ◽

pp. 417-423

Author(s):

Angelos Kyriacou ◽

Eka Melson ◽

Wentin Chen ◽

Punith Kempegowda

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Fulminant Type 1 Diabetes ◽

Fulminant Type

Download Full-text

Increased risk of immune checkpoint inhibitor–induced type 1 diabetes mellitus with the new approved 6-week scheme of pembrolizumab in patients with melanoma?

European Journal of Cancer ◽

10.1016/j.ejca.2020.07.028 ◽

2020 ◽

Vol 138 ◽

pp. 169-171 ◽

Cited By ~ 1

Author(s):

Katharina C. Kähler ◽

Katerina Kosova ◽

Ann-Sophie Bohne ◽

Sefan Schreiber ◽

Axel Hauschild

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Increased Risk

Download Full-text

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy – A multicentre study of 90 patients from the German Dermatooncology Group

European Journal of Cancer ◽

10.1016/j.ejca.2021.02.017 ◽

2021 ◽

Vol 149 ◽

pp. 1-10

Author(s):

Imke Grimmelmann ◽

Michael Momma ◽

Lisa Zimmer ◽

Jessica C. Hassel ◽

Lucie Heinzerling ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Multicentre Study ◽

Type 1 Diabetes Mellitus ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Inhibitor Therapy ◽

Checkpoint Inhibitor Therapy

Download Full-text

Type 1 diabetes mellitus with diabetic ketoacidosis after immune checkpoint inhibitor therapy

Journal of Cancer Research and Practice ◽

10.1016/j.jcrpr.2018.08.003 ◽

2018 ◽

Vol 5 (4) ◽

pp. 153-155 ◽

Cited By ~ 1

Author(s):

Po-Ya Chuang ◽

Tsu-Yi Chao ◽

Yao-Yu Hsieh

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Diabetic Ketoacidosis ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Inhibitor Therapy ◽

Checkpoint Inhibitor Therapy

Download Full-text

SUN-170 Development of Type 1 Diabetes Mellitus on Immune Checkpoint Inhibitor

Journal of the Endocrine Society ◽

10.1210/js.2019-sun-170 ◽

2019 ◽

Vol 3 (Supplement_1) ◽

Author(s):

Jessica Tsuei ◽

Christina Kwan ◽

Kjersti Kirkeby

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor

Download Full-text

Fulminant Type 1 Diabetes Mellitus Developed about Half a Year after Discontinuation of Immune Checkpoint Inhibitor Combination Therapy with Nivolumab and Ipilimumab: A Case Report

The Tohoku Journal of Experimental Medicine ◽

10.1620/tjem.254.253 ◽

2021 ◽

Vol 254 (4) ◽

pp. 253-256

Author(s):

Kazuma Yaura ◽

Kanako Sakurai ◽

Satsuki Niitsuma ◽

Ryota Sato ◽

Kazuhiro Takahashi ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Case Report ◽

Combination Therapy ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Fulminant Type 1 Diabetes ◽

Inhibitor Combination ◽

Fulminant Type

Download Full-text

A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes

Cancer Immunology Immunotherapy ◽

10.1007/s00262-016-1913-7 ◽

2016 ◽

Vol 66 (1) ◽

pp. 25-32 ◽

Cited By ~ 58

Author(s):

Young Kwang Chae ◽

Lauren Chiec ◽

Nisha Mohindra ◽

Ryan Gentzler ◽

Jyoti Patel ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor

Download Full-text

A GAD-antibody-positive patient with fulminant type 1 diabetes mellitus showing disease-resistant HLA

Diabetes Frontier Online ◽

10.15634/j0100_0301_007 ◽

2016 ◽

Vol 3 (e1) ◽

pp. 007-007

Author(s):

Nobuko Maeki

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Positive Patient ◽

Fulminant Type 1 Diabetes ◽

Disease Resistant ◽

Fulminant Type

Download Full-text

Fulminant Type 1 Diabetes Mellitus Associated with Drug Induced Hypersensitivity Syndrome by Zonisamide (Excegran)

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.70.482 ◽

2008 ◽

Vol 70 (5) ◽

pp. 482-486

Author(s):

Ikko KAJIHARA ◽

Asako ICHIHARA ◽

Jyunko HIGO ◽

Masato KIDOU ◽

Mikio TODAKA ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Hypersensitivity Syndrome ◽

Drug Induced ◽

Fulminant Type 1 Diabetes ◽

Fulminant Type

Download Full-text